Brief: Pharmacyte BiotechS Investigational New Drug Application Placed On Hold By The U.S. FDA
Oct 2 (Reuters) - PharmaCyte Biotech Inc PMCB.PK :
* PHARMACYTE BIOTECH’S INVESTIGATIONAL NEW DRUG APPLICATION
PLACED
ON HOLD BY THE U.S. FDA
* PHARMACYTE BIOTECH INC - NOTIFICATION GAVE NO DETAILS AS
TO
REASON(S) FOR FDA'S DECISION
Source text for Eikon: ID:nBwYMPkMa
Further company coverage: PMCB.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pharmacyte Biotech
See all newsBrief: Pharmacyte Biotech Inc - Increases Stake In Tnf Pharmaceuticals By $3 Million
Brief: PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease
Brief: Pharmacyte Biotech Acquires $5 Million Stake In Emerging Women’S Health Innovator Femasys
Brief: Femasys Inc. Secures Additional Financing With Strategic Investment From Investors Led By Pharmacyte Biotech
Brief: Pharmacyte Biotech Announces Final Results Of Tender Offer